Sign in

CIK 0001699382

  • Non-accelerated filer
  • Smaller reporting company

PMV Pharmaceuticals, Inc.

Sign in to watch
Ticker
PMVP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
463218129
Phone
+1 609-642-6670
Business address
400 ALEXANDER PARK DRIVE, SUITE 301, PRINCETON, NJ, 08540
  1. 4 Open-market sale Director sold 68,480 shares at an average $34.36 ($2,352,993)
  2. 4 Open-market sale Chief Medical Officer sold 4,471 shares at an average $34.04 ($152,202)
  3. 4 Open-market sale Director sold 77,693 shares at an average $36.23 ($2,814,961)
  4. 4 Open-market sale Director sold 96,136 shares at an average $35.05 ($3,369,932)
  5. 4 Open-market sale COO, CFO sold 4,500 shares at $33.82 ($152,178)
  6. 4 Open-market sale Director sold 11,024 shares at an average $35.75 ($394,149)
  7. 4 Open-market sale Director sold 17,362 shares at an average $35.91 ($623,517)
  8. 4 Open-market sale Director sold 18,872 shares at an average $35.82 ($675,953)
  9. 4 Derivatives Options or other derivatives
  10. 4 Open-market sale Director sold 3,500 shares at $35.12 ($122,929)
  11. 4 Open-market sale President and CEO sold 27,796 shares at an average $35.75 ($993,652)
  12. 4 Other disposition 10% owner disposed of 597,632 shares (other)
  13. 4 Open-market sale COO, CFO sold 4,500 shares at $33.75 ($151,875)
  14. 4 Open-market sale Chief Medical Officer sold 4,000 shares at an average $32.30 ($129,213)
  15. 4 Open-market sale President and CEO sold 204 shares at $35.53 ($7,248)
  16. 4 Open-market sale Director sold 3,500 shares at an average $33.25 ($116,362)
  17. 4 Open-market sale 10% owner sold 66,396 shares at an average $34.01 ($2,257,955)
  18. 4 Open-market sale 10% owner sold 60,271 shares at an average $33.31 ($2,007,709)
  19. 4 Open-market sale 10% owner sold 62,445 shares at an average $33.50 ($2,091,787)
  20. 4 Derivatives Options or other derivatives

Page 6 of 10 · 190 filings